A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

NCT06676007 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

IgA Nephropathy (IgAN)
Early Initial Therapy

Interventions

OTHER: Gd-IgA1 test

Sponsor

Sichuan Provincial People's Hospital